Anti-virus antibodies
Monoclonal antibodies


Cell culture & manufacturing


Anti-tumor therapies
In July 2012, Dr. Kathryn Stein established her consulting practice. Areas of interest and expertise include
  • Vaccines and biotechnology products
    • monoclonal antibodies and related products
    • polysaccharide-protein conjugate vaccines
    • biosimilars
    • biobetters
  • Conducting due diligence with respect to potential assets
  • Working with biotech companies on strategic planning for their products in the areas of
    • product/pipeline development
    • manufacturing
    • clinical
    • regulatory

Dr. Stein is a subject expert in Biotechnology and the FDA with emphasis on monoclonal antibody products and polysaccharide-protein conjugate vaccines.